Welcome to our dedicated page for Ultralife news (Ticker: ULBI), a resource for investors and traders seeking the latest updates and insights on Ultralife stock.
Ultralife Corporation (NASDAQ: ULBI) generates a steady stream of news through its quarterly earnings releases, operational updates and regulatory announcements. As a manufacturer of power solutions and communications and electronics systems serving government/defense and commercial customers, the company’s news often centers on segment performance, backlog, acquisitions and operational initiatives.
On this page, readers can follow ULBI news related to its two primary business segments: Battery & Energy Products and Communications Systems. Ultralife’s earnings releases regularly break out revenue, gross profit and operating results by segment, and management commentary highlights trends in government/defense demand, commercial markets such as medical and oil & gas, and the contribution of acquired businesses like Electrochem Solutions, Inc.
Investors and analysts tracking Ultralife’s news will see updates on actions such as the closure of a battery pack assembly facility in Calgary, Canada and the relocation of equipment and inventory to Houston, Texas, as well as commentary on supply chain conditions, tariffs, and process improvement efforts. The company also issues announcements about conference calls and webcasts for its quarterly and annual results, along with notifications of late filings when additional time is needed to complete financial reporting after acquisitions.
In addition, Ultralife files Form 8-K reports covering material events, including quarterly results and changes in its independent registered public accounting firm. For anyone following ULBI stock, this news feed provides a centralized view of the company’s publicly reported financial performance, operational decisions and governance-related disclosures over time.
Ultralife (NASDAQ: ULBI) reported Q3 2025 results: revenue $43.4M (+21.5% YoY; $36.6M ex-Electrochem, +2.5%), gross profit $9.6M (22.2% margin vs 24.3% a year ago), and GAAP EPS ($0.07) vs $0.02 prior year. The company recorded a $1.1M one-time charge (including $0.5M to close Calgary) leading to an operating loss of $1.0M; adjusted EBITDA $2.0M. Backlog exited Q3 at $90.1M vs $84.5M in Q2. Management expects Calgary closure complete in Q1 2026 with ~<$0.8M estimated annual savings.
Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Management will host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025.
Phone participants are required to pre-register at the provided registration link to receive dial-in details and a personal identification number. A live webcast will be available in the Events & Presentations section of the company website, and a replay will be posted shortly after the call.
Ultralife (NASDAQ: ULBI) filed a Form 12b-25 on Nov 7, 2025, notifying the SEC of a late Form 10-Q for the quarter ended Sept 30, 2025. The company said the late filing follows the conclusion of a transition services agreement with Integer after Ultralife completed its acquisition of Electrochem on Oct 31, 2024, and that Electrochem has moved from Integer's systems to Ultralife systems.
Ultralife stated it needs extra time for finalizing third-quarter results and completing the independent accountant review without unreasonable effort or expense, and it expects to file the Form 10-Q by Nov 17, 2025 in accordance with Rule 12b-25.
Ultralife Corporation (NASDAQ: ULBI) has secured a $5.2 million award from the U.S. Defense Logistics Agency (DLA) for its BA-5390 military batteries. The contract involves supplying lithium manganese dioxide, non-rechargeable batteries, with deliveries scheduled throughout 2026 and completion in early 2027.
This follows their previous significant BA-5390 award in 2021, which was a multi-year contract valued at up to $9.9 million. The company's BA-5390 batteries are known for their long life, safety record, and reliability in challenging conditions.
Ultralife Corporation (NASDAQ: ULBI) reported mixed Q2 2025 results with revenue increasing 13.0% to $48.6 million, primarily driven by the Electrochem acquisition. However, organic performance showed challenges with Communications Systems sales declining 57.2%. The company reported operating income of $2.3 million and GAAP EPS of $0.05, down from $0.18 in Q2 2024.
Key metrics include gross profit of $11.6 million (23.9% margin), Adjusted EBITDA of $4.1 million (8.5% of sales), and a backlog of $89 million. The company faced headwinds from tariffs and unfavorable product mix but managed to prepay $2.7 million in acquisition debt. Management expects improved performance in H2 2025 and 2026, driven by Communications Systems rebound and new product initiatives.
Ultralife Corporation (NASDAQ: ULBI) has scheduled its second quarter 2025 financial results announcement for August 7, 2025, before market opening. The company will host an investor conference call and webcast at 12:00 PM ET on the same day.
Participants joining by phone must pre-register through a provided link to ensure smooth connection. A live webcast will be accessible through the Events & Presentations section of Ultralife's investor website, with a replay available shortly after the call.
Ultralife Corporation (NASDAQ: ULBI) has scheduled its first quarter 2025 financial results announcement for May 9, 2025, before market opening. The results will cover the period ended March 31, 2025.
The company will host an investor conference call and simultaneous webcast at 10:00 AM ET on the same day. To ensure smooth participation, attendees joining by phone must pre-register through a provided link to receive dial-in information and a personal identification number.
Investors can access the live webcast through the Events & Presentations section on Ultralife's website. For those unable to attend live, a replay will be available shortly after the call at the same location.
Ultralife (NASDAQ: ULBI) reported Q4 2024 results with sales of $43.9 million, slightly down from $44.5 million in Q4 2023. The quarter saw an 11.7% increase in Battery & Energy Products sales but a 55.1% decrease in Communications Systems sales.
Key Q4 metrics include gross profit of $10.6 million (24.2% margin), operating income of $1.5 million (including $1.1 million in Electrochem acquisition costs), and GAAP EPS of $0.01. The company completed the acquisition of Electrochem on October 31, 2024, contributing $6.1 million to revenue.
For full-year 2024, sales reached $164.5 million, a 3.7% increase year-over-year, with operating income of $10.0 million and GAAP EPS of $0.38. The company's backlog and high confidence orders stood at $102.2 million exiting 2024, up from $78.0 million in Q3.
Ultralife (NASDAQ: ULBI) has announced it will release its fourth quarter results for the period ending December 31, 2024, before market opens on Tuesday, April 1, 2025. The company's management will host an investor conference call and simultaneous webcast at 8:30 AM ET on the same day.
Participants joining by phone must pre-register through a provided link to ensure reliable connection. A live webcast will be accessible through the Events & Presentations section of Ultralife's website, with a replay available shortly after the call.
FAQ
What is the current stock price of Ultralife (ULBI)?
What is the market cap of Ultralife (ULBI)?
